Experience: More than 15 years of experience from roles in clinical drug development and business development at Sanofi, Sobi and Camurus. Prior to that, he worked as a stock analyst.
Current assignments: Chairman of the Board of Atrogi AB, Board member of Targinta AB, Beactica Therapeutics AB, Cavis Technologies AB, Cordivest AB, Chateau Holding AB, Buzzard Pharmaceuticals AB, MetaCurUm Biotech AB and Amarna Holding BV. CEO of Sixera Pharma AB, Cordivest AB, Buzzard Pharmaceuticals AB and MetaCurUm Biotech AB.
Previous assignments: Board member of OxTheraAB, Addbio AB, Gesynta Pharma AB, Evident Life Försäkring AB and styrelsesuppleant i Nylof Holding AB.
Shareholding: 2,452,829
Independent in relation both to the Company and its management, as well as to major shareholders.
